Paxil Lawsuits Have Resulted in Settlements Totaling Nearly $1 Billion

Drugmaker GlaxoSmithKline has reportedly paid about $1 billion to settle Paxil lawsuits, including claims that their antidepressant caused birth defects, suicides, addiction and other problems. However, with another 600 Paxil birth defect lawsuits still pending, the company is likely to spend substantially more to satisfy jury verdicts or settle all Paxil cases.

After an examination of various public records and interviews with people familiar with the cases, a report by Bloomberg News estimates that Glaxo has spent about $390 million to settle Paxil suicide or attempted suicide lawsuits, $200 million to settle Paxil addiction and birth defect lawsuits and $400 million to resolve antitrust, fraud and design claims.

Paxil (paroxetine) is a selective serotonin reuptake inhibitor prescribed to treat depression. Approved in 1992, it has become one of the most commonly prescribed drugs in the United States, with sales of just under $1 billion last year.

Did You Know?

Change Healthcare Data Breach Impacts Millions of Customers

A massive Change Healthcare data breach exposed the names, social security numbers, medical and personal information of potentially 100 million Americans, which have now been released on the dark web. Lawsuits are being pursued to obtain financial compensation.

Learn More

Side effects of Paxil have been linked to an increased risk of suicidal tendencies in some users, including a risk of death or severe injuries from attempted suicides. A large portion of the payments made so far have gone toward Paxil settlements for claims that Glaxo failed to adequately warn users and the medical community about the risk of suicide on Paxil. Bloomberg News indicates that about 150 suicide death cases were settled for an average of $2 million each and another 300 attempted suicide cases resolved for about $300,000 each.

The use of Paxil during pregnancy has also been linked to an increased risk of birth defects for children, including persistent pulmonary hypertension in newborns (PPHN) and other heart problems. Bloomberg News reports that at least 10 Paxil lawsuits involving birth defects have settled, at an average cost of about $4 million each.

There are currently about 600 more lawsuits over Paxil birth defects pending. Following a jury award in October for $2.5 million in one of the Paxil birth defect lawsuits tried in Pennsylvania, Savvas Neophytou, a London-based Panmure Gordon analysts, told investors that Glaxo faced a potential liability of $1.5 billion in the cases.

3 Comments

  • DawnMay 13, 2010 at 2:06 am

    After 6 years on paxil I developed stage 3C breast cancer. We have NO breast cancer on either side of the family.This is VERY disturbing !

  • KristineMay 4, 2010 at 8:51 pm

    I'm a recent breast cancer survivor....i was diagosed with breast cancer january 14th,2008. Iwent through two surgeries,6 months of chemo,and 34 radiation treatments. I had been on paxil for quite some time before being diagnosed. I am concerned about paxil being related to breast cancer.

  • BrandyFebruary 13, 2010 at 4:53 am

    I've always thought thats what happened to my sister/cousin/ I was adopted,she was 35 years old and my best friend she commited suicide which was so not like her, she was the best cousin/sister in the world, I lost the last of my family. Thanks, I am angry about this still, she was never warned about this, and her poor children.

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

BioZorb Lawsuit Indicates Recalled Tissue Marker Migrated After It Failed To Absorb, Resulting in Severe Pain and Surgical Removal
BioZorb Lawsuit Indicates Recalled Tissue Marker Migrated After It Failed To Absorb, Resulting in Severe Pain and Surgical Removal (Posted 4 days ago)

Days after the FDA announced a BioZorb recall, an Arkansas woman has filed a lawsuit, indicating that her BioZorb tissue marker migrated out of position, causing pain and disfigurement, instead of harmlessly absorbing into the body as advertised.